Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea
Author(s) -
Mark H. Wilcox
Publication year - 2004
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkh176
Subject(s) - medicine , clostridium difficile , pseudomembranous colitis , gastroenterology , vancomycin , metronidazole , antibody , surgery , antibiotics , immunoglobulin a , immunoglobulin g , immunology , staphylococcus aureus , genetics , bacteria , microbiology and biotechnology , biology
Clostridium difficile diarrhoea (CDD) cases treated with intravenous immunoglobulin during a 2 year period were reviewed to determine disease severity and response to treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom